Interview with the Innovators

Interview with the Innovators

Fostering Shared Treatment Decision-Making

Setting Appropriate Patient Goals of Therapy
In the third video of this series, knowledgeable advance practice providers contribute their viewpoints on the attributes of targeted antibody drug conjugate therapy for mBC that may help some patients fulfill their treatment goals.

Managing Patient Expectations and ADC-Related Side Effects
This video is the fourth in the series where skilled discussants share their approaches to managing patient expectations of treatment and side effects associated with antibody drug conjugate therapy for mBC.

Care Team and Patient Resources and Tools for mBC

Assurance in ADC Therapy for HER2+ or HER2-Low mBC
To conclude this series, our seasoned panel describes how clinical trial and practical experiences with antibody drug conjugate therapy for mBC instill their confidence in this therapy.

Ovarian Function Suppression in Premenopausal Breast Cancer: Are We Making Progress in Educating Patients on When to Start Therapy and the Length of Therapy?
Hear from two breast cancer nurse navigators, Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, on the progress made in educating patients on when to start ovarian function suppression and the recommended duration of therapy.

How Well Do Patients Tolerate Ovarian Function Suppression? Oncology Nurse Navigators Discuss Their Experience
This Interview with the Innovator video features breast cancer nurse navigators Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, as they discuss ovarian function suppression, how patients tolerate side effects, and educating patients on expectations of treatment.

Ovarian Suppression: What Are Some of the Important Questions That Women Ask?
Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, examine fertility issues associated with ovarian function suppression and the psychosocial impact it has on young breast cancer patients.

Setting Patients’ Expectations When They Are Prescribed Combination Therapy for Premenopausal Breast Cancer
This Interview with the Innovator video features two breast cancer nurse navigators, Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, reviewing combination therapy with ovarian function suppression and its effects in breast cancer patients, including the importance of setting up-front expectations of treatment.

Oncology Nurse Navigators Discuss Their Best Practices to Encourage Premenopausal Breast Cancer Patients to Adhere to Their Therapy
Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, highlight the challenges with ovarian function suppression side effects patients face and explore tactics to encourage adherence to treatment.

Page 2 of 12

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country